Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 11
1 September 2002
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

The Antisignaling Agent SC-ααδ9, 4-(Benzyl-(2-[(2,5-diphenyloxazole- 4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric Acid, Is a Structurally Unique Phospholipid Analogue with Phospholipase C Inhibitory Activity1
Andreas Vogt; Katharine E. Pestell; Billy W. Day; John S. Lazo; Peter Wipf
View articletitled, The Antisignaling Agent SC-ααδ9, 4-(Benzyl-(2-[(2,5-diphenyloxazole- 4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric Acid, Is a Structurally Unique Phospholipid Analogue with Phospholipase C Inhibitory Activity<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Combination Therapy with AG-490 and Interleukin 12 Achieves Greater Antitumor Effects than Either Agent Alone1
Lyudmila Burdelya; Robyn Catlett-Falcone; Alexander Levitzki; Fengdong Cheng; Linda B. Mora; Eduardo Sotomayor; Domenico Coppola; JiaZhi Sun; Said Sebti; William S. Dalton; Richard Jove; Hua Yu
View articletitled, Combination Therapy with AG-490 and Interleukin 12 Achieves Greater Antitumor Effects than Either Agent Alone<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Design, Synthesis, and Biological Evaluation of a Dual Tumor-specific Motive Containing Integrin-targeted Plasmin-cleavable Doxorubicin Prodrug1
Franciscus M. H. de Groot; Henk J. Broxterman; Hans P. H. M. Adams; Alexandra van Vliet; Godefridus I. Tesser; Yvonne W. Elderkamp; Astrid J. Schraa; Robbert Jan Kok; Grietje Molema; Herbert M. Pinedo; Hans W. Scheeren
View articletitled, Design, Synthesis, and Biological Evaluation of a Dual Tumor-specific Motive Containing Integrin-targeted Plasmin-cleavable Doxorubicin Prodrug<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Inhibition of Phosphatidylinositol 3-Kinase-Akt Signaling Blocks Growth, Promotes Apoptosis, and Enhances Sensitivity of Small Cell Lung Cancer Cells to Chemotherapy1
Geoffrey W. Krystal; Geoffrey Sulanke; Julie Litz
View articletitled, Inhibition of Phosphatidylinositol 3-Kinase-Akt Signaling Blocks Growth, Promotes Apoptosis, and Enhances Sensitivity of Small Cell Lung Cancer Cells to Chemotherapy<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Transmission of Apoptosis in Human Colorectal Tumor Cells Exposed to Capecitabine, Xeloda, Is Mediated via Fas1
Joseph Ciccolini; Frédéric Fina; Karine Bezulier; Sarah Giacometti; Magali Roussel; Alexandre Evrard; Pierre Cuq; Sylvie Romain; Pierre-Marie Martin; Claude Aubert
View articletitled, Transmission of Apoptosis in Human Colorectal Tumor Cells Exposed to Capecitabine, Xeloda, Is Mediated via Fas<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Lipoxygenase Inhibitors Attenuate Growth of Human Pancreatic Cancer Xenografts and Induce Apoptosis through the Mitochondrial Pathway1
Wei-Gang Tong; Xian-Zhong Ding; Richard C. Witt; Thomas E. Adrian
View articletitled, Lipoxygenase Inhibitors Attenuate Growth of Human Pancreatic Cancer Xenografts and Induce Apoptosis through the Mitochondrial Pathway<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Histone Deacetylase Inhibitors All Induce p21 but Differentially Cause Tubulin Acetylation, Mitotic Arrest, and Cytotoxicity
Mikhail V. Blagosklonny; Robert Robey; Dan L. Sackett; Litong Du; Frank Traganos; Zbigniew Darzynkiewicz; Tito Fojo; Susan E. Bates
View articletitled, Histone Deacetylase Inhibitors All Induce p21 but Differentially Cause Tubulin Acetylation, Mitotic Arrest, and Cytotoxicity
Open the PDF for in another window
O6-Benzylguanine-mediated Enhancement of Chemotherapy1
Henry S. Friedman; Stephen Keir; Anthony E. Pegg; Peter J. Houghton; O. Michael Colvin; Robert C. Moschel; Darell D. Bigner; M. Eileen Dolan
View articletitled, <em>O</em><sup>6</sup>-Benzylguanine-mediated Enhancement of Chemotherapy<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Intratumoral Injection of Interleukin-12 Plasmid DNA, Either Naked or in Complex with Cationic Lipid, Results in Similar Tumor Regression in a Murine Model
Fushun Shi; Alexander L. Rakhmilevich; Chuck P. Heise; Katsuhisa Oshikawa; Paul M. Sondel; Ning-Sun Yang; David M. Mahvi
View articletitled, Intratumoral Injection of Interleukin-12 Plasmid DNA, Either Naked or in Complex with Cationic Lipid, Results in Similar Tumor Regression in a Murine Model
Open the PDF for in another window
Cancer Chemopreventive Activity of Xanthohumol, a Natural Product Derived from Hop 1
Clarissa Gerhauser; Axel Alt; Elke Heiss; Amira Gamal-Eldeen; Karin Klimo; Jutta Knauft; Isabell Neumann; Hans-Rudolf Scherf; Norbert Frank; Helmut Bartsch; Hans Becker
View articletitled, Cancer Chemopreventive Activity of Xanthohumol, a Natural Product Derived from Hop <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window

Review

Translation Initiation in Cancer: A Novel Target for Therapy1
Funda Meric; Kelly K. Hunt
View articletitled, Translation Initiation in Cancer: A Novel Target for Therapy<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window

Advertisement

Breaking
$500,000 Purse Announced for TBXT Drugs
B7-H4 Inhibitor Effective for Some Triple-Negative Breast Cancers
CAR-Related T-Cell Malignancies Rare, Another Study Finds
View more recent articles
Latest News
Greater Certainty of Survival Valued Over Speedier Drug Access
Keto Diet Key to Fueling CARs?
ADC for Lymphoma Elicits Near-Perfect Response Rate
View more recent articles
Research Watch
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
Glycolysis Dictates Response to Fasting-Mimicking Diet in Breast Cancer
Tumor Suppressor Gene Zygosity Can Predict Therapeutic Response in Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept